These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33603784)

  • 41. Identification of Necroptosis-Related miRNA Signature as a Potential Predictive Biomarker for Prognosis and Immune Status in Colon Adenocarcinoma.
    Ma X; Yang B; Dong H; Lin H; Wang W
    J Oncol; 2022; 2022():9413562. PubMed ID: 36065304
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of a prognostic and therapeutic immune signature associated with hepatocellular carcinoma.
    Peng Y; Liu C; Li M; Li W; Zhang M; Jiang X; Chang Y; Liu L; Wang F; Zhao Q
    Cancer Cell Int; 2021 Feb; 21(1):98. PubMed ID: 33568167
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
    Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
    Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.
    Chen L; Jiang M; Yuan W; Tang H
    J Invest Surg; 2012 Jun; 25(3):156-61. PubMed ID: 22583011
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Similar Effects of miR-512-3p and miR-519a-2-5p on the Promotion of Hepatocellular Carcinoma: Different Tunes Sung With Equal Skill.
    Rui T; Zhang X; Feng S; Huang H; Zhan S; Xie H; Zhou L; Ling Q; Zheng S
    Front Oncol; 2020; 10():1244. PubMed ID: 32850377
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Construction of a prognostic model based on nine immune-related genes and identification of small molecule drugs for hepatocellular carcinoma (HCC).
    Zhang J; Chen G; Zhang J; Zhang P; Ye Y
    Am J Transl Res; 2020; 12(9):5108-5130. PubMed ID: 33042409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A novel seven-gene signature as Prognostic Biomarker in Hepatocellular Carcinoma.
    Xie H; Liu S; Zhang Z; Chen P; Tao Y
    J Cancer; 2020; 11(19):5768-5781. PubMed ID: 32913470
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune-Related Nine-MicroRNA Signature for Predicting the Prognosis of Gastric Cancer.
    Xu J; Wen J; Li S; Shen X; You T; Huang Y; Xu C; Zhao Y
    Front Genet; 2021; 12():690598. PubMed ID: 34290743
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.
    Krishnan P; Ghosh S; Wang B; Li D; Narasimhan A; Berendt R; Graham K; Mackey JR; Kovalchuk O; Damaraju S
    BMC Genomics; 2015 Sep; 16():735. PubMed ID: 26416693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers is Mainly Dependent on HER2 Status-A Pilot Study.
    Kunc M; Popęda M; Niemira M; Szałkowska A; Bieńkowski M; Pęksa R; Łacko A; Radecka BS; Braun M; Pikiel J; Litwiniuk M; Pogoda K; Iżycka-Świeszewska E; Krętowski A; Żaczek AJ; Biernat W; Senkus-Konefka E
    Diagnostics (Basel); 2020 Aug; 10(9):. PubMed ID: 32825530
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated Analysis of lncRNA-Mediated ceRNA Network Reveals a Prognostic Signature for Hepatocellular Carcinoma.
    Sun JR; Kong CF; Xiao KM; Yang JL; Qu XK; Sun JH
    Front Genet; 2020; 11():602542. PubMed ID: 33381151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
    Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Oncogenic value of microRNA-15b-5p in hepatocellular carcinoma and a bioinformatics investigation.
    Pan WY; Zeng JH; Wen DY; Wang JY; Wang PP; Chen G; Feng ZB
    Oncol Lett; 2019 Feb; 17(2):1695-1713. PubMed ID: 30675229
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Identification of a three-miRNA signature as a novel prognostic model for papillary renal cell carcinoma.
    Li G; Yang H; Cheng Y; Zhao X; Li X; Jiang R
    Cancer Cell Int; 2020; 20():317. PubMed ID: 32694939
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MiR-542-3p inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting UBE3C.
    Tao J; Liu Z; Wang Y; Wang L; Yao B; Li Q; Wang C; Tu K; Liu Q
    Biomed Pharmacother; 2017 Sep; 93():420-428. PubMed ID: 28666208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma.
    Chen W; Ou M; Tang D; Dai Y; Du W
    J Immunol Res; 2020; 2020():5494858. PubMed ID: 32211443
    [TBL] [Abstract][Full Text] [Related]  

  • 57. High expression of serum miR-17-5p associated with poor prognosis in patients with hepatocellular carcinoma.
    Zheng J; Dong P; Gao S; Wang N; Yu F
    Hepatogastroenterology; 2013 May; 60(123):549-52. PubMed ID: 23108086
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A five-miRNA expression signature predicts survival in hepatocellular carcinoma.
    Liu G; Wang H; Fu JD; Liu JY; Yan AG; Guan YY
    APMIS; 2017 Jul; 125(7):614-622. PubMed ID: 28430373
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of a Novel Six-miRNA-Based Model to Predict Overall Survival Among Colon Adenocarcinoma Patients.
    Rong Z; Rong Y; Li Y; Zhang L; Peng J; Zou B; Zhou N; Pan Z
    Front Oncol; 2020; 10():26. PubMed ID: 32154160
    [No Abstract]   [Full Text] [Related]  

  • 60. Identification of a Potential PPAR-Related Multigene Signature Predicting Prognosis of Patients with Hepatocellular Carcinoma.
    Xu W; Chen Z; Liu G; Dai Y; Xu X; Ma D; Liu L
    PPAR Res; 2021; 2021():6642939. PubMed ID: 33777129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.